Artiva Biotherapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
RA Capital Management and its affiliates have disclosed an increased beneficial ownership stake in Artiva Biotherapeutics, Inc. to 37.9% through recent open market purchases.
NASDAQ
RA Capital Management has increased its beneficial ownership in Artiva Biotherapeutics to 36.6% following a series of open market purchases.
NASDAQ
RA Capital Management reports a significant increase in its beneficial ownership of Artiva Biotherapeutics following a $100 million public offering participation.